Moclobemide
SIGMA/M3071 - ≥98% (HPLC), solid
Synonym: 4-Chloro-N-
CAS Number: 71320-77-9
Empirical Formula (Hill Notation): C13H17ClN2O2
Molecular Weight: 268.74
MDL Number: MFCD00865388
Linear Formula: C13H17ClN2O2
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white |
| form | solid |
| InChI | 1S/C13H17ClN2O2/c14-12-3- |
| InChI key | YHXISWVBGDMDLQ-UHFFFAOYSA |
| originator | Roche |
| Quality Level | 100 ![]() |
| SMILES string | Clc1ccc(cc1)C(=O)NCCN2CCO |
| solubility | DMSO: >20 mg/mL |
| storage temp. | room temp |
| Biochem/physiol Actions: | Moclobemide acts as a substrate for cytochrome P450 2C19 (CYP2C19). It also behaves as an inhibitor of cytochrome P450 2D6 (CYP2D6), cytochrome P450 1A2 (CYP1A2 and CYP2C19. Moclobemide is also involved in the increased expression of B-cell lymphoma 2 (BcL-2). It also causes neural stem cell (NSC) differentiation into serotoninergic neuron by extracellular‐regulated kinase (ERK) pathway. |
| Biochem/physiol Actions: | Moclobemide is a reversible monoamine oxidase A inhibitor (MAOI); antidepressant. |
| Biochem/physiol Actions: | Moclobemide is a reversible monoamine oxidase A inhibitor (MAOI); antidepressant. Elimination half-life in humans = 1 -3 hrs; absolute oral bioavailability. Unlike other MAO inhibitors, does not significantly increase blood pressure in humans upon combination with tyramine. |
| Features and Benefits: | This compound is featured on the Dopamine and Norepinephrine Metabolism page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Features and Benefits: | This compound was developed by Roche . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | ![]() GHS05,GHS07 |
| Signal word | Danger |
| Hazard statements | H302 - H315 - H318 - H335 |
| Precautionary statements | P280 - P301 + P312 + P330 - P302 + P352 - P305 + P351 + P338 + P310 |
| Hazard Codes | Xn |
| Risk Statements | 22-37/38-41 |
| Safety Statements | 26-39 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 2 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | room temp |
| UNSPSC | 12352200 |



